Sabag Mark sold TEVA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001193125-26-451814

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 5, 2026

Published

Nov 6, 2026

Ingested by INSIDER

Nov 6, 22:10 UTC

Last re-read

Nov 6, 22:10 UTC

Extracted facts

Filer

Sabag Mark

Role

See "Remarks"

Transaction

Open-market saleAs filed: “S”

Asset

TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker

TEVA

Shares

46.0K

Price per share

$41.93

Value

$1,928,729

Execution date (reported)

Nov 5, 2026

Owned after transaction

80.8K shares

Days from execution to publication

1

Calculation

What this establishes

Sabag Mark filed this Form 4 reporting a open-market sale of TEVA on Nov 5, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

See "Remarks"

Sabag Markcik:0001721442

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTDcik:0000818686

Revision history · 0

No field has changed since this record was first ingested.